SHORT-COURSE CHEMOTHERAPY IN PULMONARY TUBERCULOSIS: A Controlled Trial by the British Thoracic and Tuberculosis Association
- 18 January 1975
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 305 (7899), 119-124
- https://doi.org/10.1016/s0140-6736(75)91426-9
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- FOLLOW-UP OF PATIENTS WITH PULMONARY TUBERCULOSIS ADEQUATELY TREATED BY CHEMOTHERAPY: IS THIS REALLY NECESSARY ?The Lancet, 1974
- Serum enzyme changes in patients receiving antituberculosis therapy with rifampicin or p-aminosalicylic acid, plus isoniazid and streptomycinTubercle, 1974
- Effect of Rifampicin and Isoniazid on Liver FunctionBMJ, 1972
- Improvement of drug-sensitivity tests on tubercle bacilliTubercle, 1970
- A two-year follow-up of 181 sputum-positive tuberculosis patients treated in Gateshead between 1961 and 1966Tubercle, 1970
- Patients' preference of drugs in the treatment of tuberculosisTubercle, 1969
- Radiology in epidemiological studies and some therapeutic trials.BMJ, 1966
- Long-term chemotherapy in the treatment of chronic pulmonary tuberculosis with cavitation: A report to the Medical Research Council by their Tuberculosis Chemotherapy Trials CommitteeTubercle, 1962
- Tuberculosis UndefeatedBMJ, 1960
- Hospital Treatment of Pulmonary TuberculosisBMJ, 1958